Vanguard Personalized Indexing Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.51M | Sell |
10,013
-1,227
| -11% | -$305K | 0.02% | 526 |
|
|
2025
Q4 | $3.09M | Buy |
11,240
+16
| +0.1% | +$4.38K | 0.03% | 450 |
|
|
2025
Q3 | $2.94M | Buy |
11,224
+1,322
| +13% | +$321K | 0.03% | 453 |
|
|
2025
Q2 | $2.17M | Buy |
9,902
+1,804
| +22% | +$386K | 0.02% | 542 |
|
|
2025
Q1 | $1.81M | Sell |
8,098
-2,734
| -25% | -$753K | 0.03% | 525 |
|
|
2024
Q4 | $3.55M | Buy |
10,832
+2,906
| +37% | +$915K | 0.05% | 310 |
|
|
2024
Q3 | $2.38M | Sell |
7,926
-3,876
| -33% | -$1.19M | 0.04% | 415 |
|
|
2024
Q2 | $3.86M | Sell |
11,802
-114
| -1% | -$40.3K | 0.07% | 234 |
|
|
2024
Q1 | $4.72M | Buy |
11,916
+278
| +2% | +$103K | 0.1% | 181 |
|
|
2023
Q4 | $4.1M | Buy |
11,638
+698
| +6% | +$247K | 0.11% | 174 |
|
|
2023
Q3 | $4.1M | Buy |
10,940
+657
| +6% | +$254K | 0.12% | 146 |
|
|
2023
Q2 | $3.93M | Buy |
10,283
+320
| +3% | +$114K | 0.12% | 148 |
|
|
2023
Q1 | $3.45M | Buy |
9,963
+1,058
| +12% | +$309K | 0.12% | 159 |
|
|
2022
Q4 | $2.1M | Buy |
8,905
+537
| +6% | +$127K | 0.09% | 253 |
|
|
2022
Q3 | $2.06M | Sell |
8,368
-68
| -0.8% | -$20.7K | 0.09% | 219 |
|
|
2022
Q2 | $2.55M | Buy |
8,436
+632
| +8% | +$206K | 0.12% | 164 |
|
|
2022
Q1 | $3.21M | Buy |
7,804
+1,091
| +16% | +$427K | 0.16% | 110 |
|
|
2021
Q4 | $3.15M | Buy |
6,713
+5,119
| +321% | +$2.2M | 0.19% | 96 |
|
|
2021
Q3 | $677K | Buy |
1,594
+317
| +25% | +$134K | 0.06% | 366 |
|
|
2021
Q2 | $459K | Buy |
1,277
+481
| +60% | +$159K | 0.05% | 524 |
|
|
2021
Q1 | $224K | Buy |
796
+61
| +8% | +$17.5K | 0.03% | 631 |
|
|
2020
Q4 | $208K | Buy |
+735
| New | +$206K | 0.05% | 497 |
|
Other funds holding WST
VCM
VPM
GIM
